Veliparib is a benzimidazole derivative with a carbamoyl group and a pyrrolidinyl substituent. It is a potent, orally bioavailable inhibitor of poly(ADP-ribose) polymerase (PARP), acting as an EC 2.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 912444-00-9
8-Fluoro-2-(4-((methylamino)methyl)phenyl)-1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd)indol-6-one
PARP inhibitor active pharmaceutical ingredient
DIFLOXACIN HYDROCHLORIDE
active pharmaceutical ingredient
SARAFLOXACIN HYDROCHLORIDE
Antibacterial active pharmaceutical ingredient
Cenobamate
active pharmaceutical ingredient
(1S)-1-(2-chlorophenyl)-2-(2H-1,2,3,4-tetrazol-2-yl)ethyl carbamate
active pharmaceutical ingredient impurity
2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide
JNAHVYVRKWKWKQ-CYBMUJFWSA-N
C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N